BECLOMETHASONE DIPROPIONATE
| Brand name | QNASL |
|---|---|
| Active ingredient | BECLOMETHASONE DIPROPIONATE |
| Strength | 0.08MG/ACTUATION |
| Dosage form | AEROSOL, METERED |
| Route | NASAL |
| Modality | Small molecule |
| FDA approval | March 2012 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 10188811 | October 2031 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.